Iberian Analytical
Planned / pre-launch facilityNavarra, Spain
Planned facility: pre-launch, service commencement Q1 2027; Facility city not published; country only. The criteria below are still shown for transparency.
Overview
Iberian Analytical is a Spanish limited company registered in Navarra, described on its own website as an EU-based analytical laboratory for research peptides. The site states it is in a pre‑launch phase, with service commencement targeted for Q1 2027, and that "nothing is sold on this site today." Planned services include HPLC purity testing, duplicate mg/vial quantification against reference standards, and presumptive identity by retention-time co-elution, with a mass-spectrometry identity add-on. The site states a target turnaround of 48-72 hours once operating, publishes a flat per-analyte price list, and describes a planned public database for verifying certificates by task ID and QR code. It states ISO/IEC 17025 accreditation application is planned for year one and describes a planned blind calibration exercise against an unnamed established lab prior to launch. Details are summarised from the company's own website and have not been independently audited.
Key facts
| Business type | Planned / pre-launch facilityAnnounced or in pre-launch and not confirmed as operating. Services, prices and turnaround times are labelled as planned, not currently available. Not ranked. |
|---|---|
| Operating status | Planned — pre‑launch, service commencement Q1 2027As stated on the company’s site, checked 2026-09-30“STATUS: PRE‑LAUNCH · SERVICE COMMENCEMENT Q1 2027” source “Iberian Analytical opens in Q1 2027 — from €99 per test, 48–72 h target, and every report verifiable. Nothing is sold on this site today.” source |
| Website | iberianalytical.com |
| Public contact | info@iberianalytical.com · Contact page |
| Legal entity | Iberian Analytical (Spanish limited company, Navarra) source |
| Sample submission / quote | Associate account application (open now; testing starts Q1 2027)Quote request source |
| Accreditation | ISO/IEC 17025 application planned in year one; not yet accredited (not counted: no accreditor/certificate, or not yet granted) source |
| Pricing | Planned (Q1 2027)Base purity + quantification test: €99 per vial source Semaglutide testing: €149 per vial source MS identity confirmation add-on: +€79 source Extended CoA data add-on: +€15 source |
| Turnaround | Planned target (Q1 2027)48-72 hour target turnaround from receipt source 48-72 hours target turnaround source MS add-on adds 5-7 days source |
| Report verification | Planned (Q1 2027)Announced, not yet available source |
| Sample report | Specimen onlyPublished source |
| Partner laboratories | Planned blind calibration round with an unnamed 'market-leading lab' before launch source External cross-check laboratory for related-party product (unnamed) source |
Confirmed locations
- Planned testing facility Navarra, Spain source
Testing services (planned)
| Service | Method (as published) | Source |
|---|---|---|
| Planned (Q1 2027)Purity (HPLC/UPLC)Purity | RP-HPLC-UV at 214 nm, C18 column, water/acetonitrile gradient + 0.1% TFA | source |
| Planned (Q1 2027)IdentityIdentity | Retention-time co-elution (presumptive); MS confirmation add-on | source |
| Planned (Q1 2027)Quantity / net contentQuantity | HPLC quantification vs reference standard, duplicate preparation | source |
| Planned (Q1 2027)Other analysesGLP-1 blind identification panel | RT identification vs standards plus purity and quantification | source |
These services are planned (q1 2027), as published by the company. They are not confirmed as currently available.
Evaluation criteria
PAL Testing Evidence Score v1. How it works. – means not found in public sources as of 2026-09-30; it is not a finding that the facility lacks it.
Facility transparency
- –Street address publishedNot found in public sources. A street address (not a PO box, registered agent or mailing address) is published on the company's own site.
- ✓Address identified as the testing facility or sample intakeAnnounced (planned facility). The site ties an address to the laboratory or to where samples are received.
- ✓Legal entity namedDocumented. The operating company's legal name is published.
- –Named scientific staffNot found in public sources. At least one scientist or lab lead is named.
Analytical scope
- ✓Purity testing (HPLC/UPLC)Announced, not yet available. Chromatographic purity testing is offered.
- ✓Identity testing (method named)Announced, not yet available. Identity confirmation is offered and the method is named (e.g. LC-MS, MALDI-TOF). Mass spectrometry counts.
- ✓Quantity / net contentAnnounced, not yet available. Quantitation of the amount in the vial is offered.
- –EndotoxinNot found in public sources. Bacterial endotoxin testing is offered.
- –Culture-based sterility (e.g. USP <71>)Not found in public sources. Compendial or culture-based sterility testing. PCR or rapid screens are listed but do not earn this point.
- –Heavy metals / elementalNot found in public sources. Heavy-metal or elemental analysis is offered.
Quality & reporting
- ✓Method detail documentedAnnounced, not yet available. The site documents how analyses are run (instrument, column, detector, reference standards or validation), not just a technique name.
- –Accreditation stated with accreditor or certificate numberNot found in public sources. An accreditation such as ISO/IEC 17025 is stated with the accrediting body or certificate number. 'Pending', 'aligned' or 'compliant' statements do not count.
- –Accreditation found in the accreditor's public directoryNot found in public sources. PAL found the accreditation in the accrediting body's public directory, or a verified owner submitted it and PAL confirmed it there.
- ✓Public report verification lookupAnnounced, not yet available. Anyone can check a report's authenticity by ID or QR code.
- ✓Sample report publishedAnnounced, not yet available. An example report or COA can be viewed.
Ordering transparency
- ✓Concrete pricing publishedAnnounced, not yet available. At least one concrete price is published.
- ✓Turnaround time publishedAnnounced, not yet available. A concrete turnaround time is published.
- ✓Online ordering, submission or quote linkAnnounced, not yet available. An online order, sample submission form or quote request is available.
Is this your facility?
Claiming is free. PAL first verifies that you are authorized to act for the business. Verified owners can then use three separate routes. Peptide Ad Lab never charges a business to correct a factual inaccuracy.
- Company-provided updatesYour description, testing services, methods and instruments, facility locations, sample submission link, turnaround, pricing and contact details, shown in a section labelled “Provided by the company”. Not checked by PAL and not used in the score. Free: sent to PAL as correction requests. PAL Pro: published directly.
- PAL-reviewed evidenceDocuments or links for a scoring criterion. PAL reviews them under the same rule used for every facility; only accepted evidence changes a finding. Any plan.
- PAL-verified lab credentialsAccreditations such as ISO/IEC 17025. They count only after PAL finds them in the accreditor’s public directory. Any plan.
PAL Pro is an optional paid plan for company-provided updates, extra images and the PAL Pro badge. It never verifies a credential, accepts evidence, or changes a finding, score, eligibility or ranking position.
Ownership verification confirms that you control the business. It is separate from laboratory credentials and from PAL Pro, it is not an endorsement, and it does not change any finding or score.
Claim This ProfileSources
Last reviewed 2026-09-30. All facts above were taken from these pages on the company’s website.
- https://iberianalytical.com/
- https://iberianalytical.com/pricing
- https://iberianalytical.com/learn/testing/semaglutide
- https://iberianalytical.com/governance
- https://iberianalytical.com/database
- https://iberianalytical.com/methodology
Peptide Ad Lab has not tested samples at or audited this facility. Information is summarised from public sources and may change. Businesses can claim this profile to request corrections.